diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md
index c1791787..f9274b10 100644
--- a/pages/STOP2030___Web___Posts.md
+++ b/pages/STOP2030___Web___Posts.md
@@ -11,4 +11,6 @@
 	  
 	  The clinical trial will have two arms, randomized by school. One arm will receive a single dose of the fixed-dose coformulation tablet (alb 400mg/ivm 9mg for children between 5 and 14 years old, alb 400mg/ivm 18mg for 15-17s), while the other, acting as an active control group, will receive a single dose of albendazole 400mg.
 	  
+	  If you want to review the full protocol, please visit the REALISE study's page at clinicaltrials.gov or PACTR.
+	  
 	  #+END_VERSE
\ No newline at end of file